Swift Biosciences - Wiki

Swift provides research tools for long term improvements in the health of individuals and their communities all around the world, specifically in the fight against cancer and understanding the complexities of inherited diseases.

Timeline

November 2018

Swift Biosciences raises a $4,000,000 venture round.

July 2017

Swift Biosciences raises a $12,200,000 series D round from Arboretum Ventures.

April 2016

Swift Biosciences raises a $3,000,000 series C round from Draper Associates, Fletcher Spaght Ventures and Michigan Accelerator Fund I.

September 2015

Swift Biosciences raises a $1,500,000 venture round.

October 17, 2013

Swift Biosciences raises a $7,000,000 series B round from Fletcher Spaght Ventures, Mercury Fund and Renaissance Venture Capital Fund.

February 2012

Swift Biosciences raises a $500,000 venture round.

August 19, 2010

Swift Biosciences raises a $3,000,000 series A round from Mercury Fund.

2009

Swift Biosciences was founded by Timothy Harkins.

Funding Rounds

Patents

Further Resources

Title

Author

Link

Type

Date

News

Title

Author

Date

Publisher

Description

Swift Biosciences and SPT Labtech Announce Accelerated Research Collaboration

Swift Biosciences

March 4, 2021

www.prnewswire.com:443

/PRNewswire/ -- Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) and SPT Labtech,...

Genemarkers LLC & Swift Biosciences Detect Unexpected Variant from COVID-19 S Gene Dropout Samples from Kalamazoo, MI

Swift Biosciences

February 18, 2021

www.prnewswire.com:443

/PRNewswire/ -- Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library...

Swift Biosciences Accelerates its Global Expansion in China and Asia Pacific

Swift Biosciences

February 4, 2021

www.prnewswire.com:443

/PRNewswire/ -- A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces...

Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2

Swift Biosciences

January 27, 2021

www.prnewswire.com:443

/PRNewswire/ -- Swift Biosciences of Ann Arbor, MI has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers....